299409-85-1Clarithromycin EP Impurity B
● In Stock
| Catalogue No.: | VE009557 |
|---|---|
| CAS No.: | 299409-85-1 |
| Mol. Formula: | C37H67NO13 |
| Mol. Weight: | 733.93 g/mol |
Additional information on CAS 299409-85-1
Parent drug
ClarithromycinIUPAC Name
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-(((2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12, 13-dihydroxy-4-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3, 5, 7, 9, 11, 13, 14-heptamethyloxacyclotetradecane-2, 10-dioneSynonyms
6-O-Methyl-15-norerythromycin ADescription
Clarithromycin EP Impurity B (CAS No: 299409-85-1) Or (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13,14-heptamethyloxacyclotetradecane-2,10-dione,It is an impurity of Clarithromycin, is a macrolide antibiotic and a semisynthetic macrolide antibiotic, that is used to treat bacterial infections pharyngitis, tonsillitis, respiratory tract infections. it has a semisynthetic macrolide antibiotic. it has 70% protein bound and is well-absorbed, acid stable.References
Kanatani, M. S., & Guglielmo, B. J. (1994). The new macrolides. Azithromycin and clarithromycin. The Western Journal of Medicine, 160(1), 31–37. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1022251/Request a Quote
"*" indicates required fields









